Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
25.63 EUR | -0.78% | +7.79% | -1.67% |
11:17am | GSK plc : Back on track | |
12:23am | Wall Street: optimism ahead of NFP, rates ease | CF |
Sales 2024 * | 60.13B 55.83B 82.29B | Sales 2025 * | 62.49B 58.02B 85.52B | Capitalization | 157B 146B 215B |
---|---|---|---|---|---|
Net income 2024 * | 7.91B 7.34B 10.82B | Net income 2025 * | 10.19B 9.46B 13.95B | EV / Sales 2024 * | 3.5 x |
Net Debt 2024 * | 53.77B 49.92B 73.58B | Net Debt 2025 * | 42.59B 39.54B 58.28B | EV / Sales 2025 * | 3.19 x |
P/E ratio 2024 * |
18.4
x | P/E ratio 2025 * |
13.7
x | Employees | 88,000 |
Yield 2024 * |
6.11% | Yield 2025 * |
6.22% | Free-Float | 59.09% |
Latest transcript on Pfizer, Inc.
1 day | -0.78% | ||
1 week | +7.79% | ||
Current month | +6.98% | ||
1 month | +1.70% | ||
3 months | +3.28% | ||
6 months | -12.11% | ||
Current year | -1.67% |
Managers | Title | Age | Since |
---|---|---|---|
Albert Bourla
CEO | Chief Executive Officer | 62 | 92-12-31 |
David Denton
DFI | Director of Finance/CFO | 59 | 22-05-01 |
Jeff Settleman
CTO | Chief Tech/Sci/R&D Officer | - | 19-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 66 | 20-03-31 | |
Ronald Blaylock
BRD | Director/Board Member | 64 | 17-02-22 |
Shantanu Narayen
BRD | Director/Board Member | 60 | 13-09-26 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 25.66 | -0.64% | 5 626 |
24-05-02 | 25.83 | +7.67% | 11,652 |
24-04-30 | 23.99 | +0.38% | 3,894 |
24-04-29 | 23.9 | +0.38% | 11,246 |
24-04-26 | 23.81 | +0.53% | 6,979 |
Delayed Quote Deutsche Boerse AG, May 03, 2024 at 10:36 am
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+25.57% | 681B | |
+21.85% | 556B | |
-5.16% | 361B | |
+17.11% | 325B | |
+4.71% | 285B | |
+13.45% | 235B | |
+3.64% | 199B | |
-11.17% | 189B | |
+9.00% | 149B |
- Stock Market
- Equities
- PFE Stock
- PFE Stock